Development of a vaccine based on sperm antigens represents a promising approach to contraception. The sperm-zona pellucida (ZP) interaction constitutes the most important event in the fertilization process, and the molecular sequences involved at this site may provide the most attractive candidates for immunocontraception. In the present study, using the phase peptide display technique, a novel dodecamer sequence, designated as YLP 12 , was identified that is involved in sperm-ZP recognition/binding. The synthetic 12-mer peptide based on this sequence and its monovalent Fab antibodies specifically and significantly (P Ͻ 0.05) inhibited human sperm-ZP binding. In Western blot and immunoprecipitation procedures, the YLP 12 peptide recognized the ZP3 component of solubilized human ZP proteins. In the Western blot procedure involving 10 different human tissue extracts, the anti-YLP 12 Fab antibodies recognized a protein band of ϳ72 ؎ 2 kDa only in the testis lane. The peptide sequence was localized on the acrosomal region of the human sperm cell. These findings indicate that the novel testis-specific 12-mer YLP 12 that is present in the acrosomal region and is involved in human sperm-ZP interaction may find applications in contraceptive vaccine development, as well as in diagnosis and treatment of male infertility mediated through sperm dysfunction.
INTRODUCTION
Development of a vaccine based on sperm antigens represents a promising approach to contraception [1, 2] . The rationale and feasibility of this approach are provided by experimental immunization studies as well as data from involuntary infertility and vasectomy. Deliberate immunization of male and female animals of various species [3] [4] [5] and humans [6, 7] with extracts of spermatozoa or mature testes raises an antisperm immune response resulting in infertility. Up to 30% of infertility may be associated with the presence of antisperm antibodies (ASA) in the male and/or female partner of an infertile couple [8] , and 70% of vasectomized men form ASA [9, 10] . These ASA are not merely associated with but rather are causative factors of infertility [8, 11, 12] . Thus, the sperm cell has both auto-and iso-antigenic potentials and can generate an immune response in both men and women that is capable of inducing infertility. The utility of a sperm antigen in the development of a contraceptive vaccine is contingent on its involvement in the fertilization process and on tissue specificity. During the past decade, several antigens relevant to fertility have been defined (reviewed in [1] ). A few of these also affect fertility in actively immunized animals [1, 13] . In these studies, purified/semipurified cognate antigens were used for immunization to examine the effect on fertility. However, to obtain Food and Drug Administration approval and to conduct appropriate multicenter fertility trials in a quality-controlled manner, recombinant or synthetic peptide molecules are required. Complementary DNAs encoding for a few sperm antigens have been cloned and sequenced, and the recombinant proteins or their peptides expressed by some of the cloned cDNAs are being examined for their effect on fertility [14] [15] [16] .
The fertilization process includes a cascade of events that the spermatozoon must undergo before fusing with the oocyte plasma membrane. One of the key steps in the fertilization cascade is the recognition and binding between the complementary molecules present on the spermatozoon and zona pellucida (ZP) of the oocyte [17] . The sperm-ZP interaction constitutes an important event in the fertilization process, and the molecular sequences involved are the most attractive candidates for the development of a contraceptive vaccine.
On the basis of the above findings, the present study was conducted to investigate the sperm peptide sequence(s) involved in recognition and binding to the complementary molecule of the ZP in humans. This was achieved by screening the FliTrx random phage display library (Invitrogen, San Diego, CA) that has expression of 1.77 ϫ 10 8 different peptide sequences. A solubilized preparation of human oocyte ZP proteins was used as a probe to obtain reactive clones. The long-term objective of this study was to search for sperm peptide sequence(s) that can find potential applications in the development of a contraceptive vaccine and in the diagnosis and treatment of infertility in humans.
MATERIALS AND METHODS

Library Screening by Panning
The FliTrx random phage display library used in the present study was obtained from Invitrogen. The library was screened with solubilized human ZP proteins (HZP) according to the manufacturer's protocol. After the fifth round of panning, the eluted cells were streaked on LB plates containing 100 g/ml ampicillin to select colonies. Potential positive colonies were further confirmed for reactivity with HZP using the Western blot procedure. The colonies were grown and cells were suspended in 100 l SDS-PAGE buffer (nonreduced), boiled for 10 min, and centrifuged; the supernatant was run in SDS-PAGE (5-15% gradient gel) [18] , and the resolved proteins were trans-ferred to nitrocellulose paper for Western blot analysis [19] . The blot was reacted with HZP (20 g/20 ml) and then with rabbit antibodies to HZP (described below; 10 g/20 ml); the reacted proteins were localized by incubating the antibody-reacted strips first with alkaline phosphatase-conjugated goat anti-rabbit antibodies (heavy-and light-chain specific; Cooper Biomedical Inc., Malvern, PA) and then with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate as substrate, as described elsewhere [16, 20] .
Human Oocyte ZP Proteins and Their Antibodies
The human oocytes were obtained from female partners (21-35 yr old) of infertile couples who attended the Infertility Service for in vitro fertilization-embryo transfer [21, 22] . These infertile couples had infertility attributed to the male partners, and the female partners were without any ovarian abnormality. Appropriate informed consent and Institutional Review Board approval were obtained for study participation and collection of ova. There were an excess number of left-over mature eggs, cryopreserved in 3.5 M propanediol containing 0.27 sucrose and 5% BSA in PBS until used. These eggs were never exposed to sperm and could have otherwise been discarded. They were rapidly thawed, washed in Ham's F-10 medium, and freed of adhering granulosa cells by incubation with 0.1% hyaluronidase (Sigma Chemical Co., St. Louis, MO) in PBS. The eggs were washed (3 times) in PBS to remove adhering cumulus cells, and the zonae were heat solubilized in sodium carbonate buffer (0.001 M, pH 9.0) at 60ЊC for 1 h [21, 22] . The solubilized HZP were dialyzed against PBS for 48 h at 4ЊC before use.
Rabbit antiserum was prepared against HZP as described elsewhere [23] . Briefly, sexually mature virgin female rabbits (n ϭ 2) were actively immunized systemically with HZP emulsified with Freund's adjuvant; and after three booster injections, the animals developed high titer antibodies (Ͼ 1:5012) against HZP, as examined using ELISA. Preimmune serum and the sera from control animals injected similarly with only PBS, emulsified with Freund's adjuvant, were used as positive controls in various assays.
DNA Isolation and Sequencing
DNA was isolated from the uninduced cells/clones that showed positive reaction with HZP in the Western blot procedure after five cycles of panning. The plasmid DNA was isolated using the simple nucleic acid preparation (S.N.A.P.) miniprep kit (cat. #K1900-01; Invitrogen) and sequenced by dsDNA Cycle Sequencing System (Gibco-BRL, Gaithersburg, MD) [16, 20] . Sequencing primers were FliTrx forward and reverse sequencing primers. The 36 base pairs corresponding to the dodecamer peptide sequence were inserted at RsrII/AvaII (5Ј end) and AvaII (3Ј-end) of the vector DNA and could be released using AvaII. The search for nucleotide (nt) and amino acid (aa) sequence homology in GenBank, National Biomedical Research Foundation (NBRF), and Swiss sequence banks was performed using Fasta and tFasta search programs [24] . The consensus aa sequence was derived from the various positive peptide sequences by using the Lineup program (Genetics Computer Group, Madison, WI). The peptides were synthesized by solid-phase synthesis using Fmoc chemistry (Biosynthesis Inc., Lewisville, TX). Deprotection was achieved by 20% piperidine in dimethylformamide, and the peptides were cleaved from the resin by 85% trifluoroacetic acid (TFA). The peptides were then precipitated in methyl tert-butyl ether and purified by using reverse-phase HPLC. The fractions eluted with 0.5% TFA in acetonitrile were dried in a speed vacuum, redissolved in water, and lyophilized. All four peptides were water soluble and had Ͼ 95% purity level.
Antibodies to Peptide
The peptides were conjugated to tetanus toxoid (TT; Wyeth Laboratories, Radnor, PA) by the method described by Tsong et al. [25] , using 1-ethyl-3 (3-dimethylaminopropyl). Antiserum was raised in sexually mature virgin female rabbits of the New Zealand white strain [23] , and the antibodies were purified by using a protein A-Sepharose 4B column. The monovalent FabЈs were prepared using pepsin by the method of Nisonoff and colleagues [26] or described elsewhere [27] . The FabЈs were further immunoaffinity purified by using peptide-BSA-Sepharose 4B immunobeads prepared as described below.
Hemizona Assay
The hemizona assay was performed to examine the effects of peptides and their FabЈ antibodies on human sperm-ZP binding [28] . One half of the hemizona pair was experimental (treated with the peptide or FabЈs), and the other half of the same oocyte was used as a control (untreated). Two sets of experiments were performed. In the first set, peptide/FabЈs were incubated (37ЊC, 1 h) with sperm (100-l drop), washed, and then incubated (4 h) with the untreated experimental hemizona. Control sperm were incubated with the medium only. In the second set, peptide/ FabЈs were incubated (37ЊC, 1 h) with the experimental hemizona, washed, and then incubated (4 h) with the untreated sperm in a 100-l drop. Control hemizonae were incubated with the medium only. The number of sperm tightly bound to the outer surface of the hemizona was determined and expressed as the hemizona index: HZI ϭ [Number of sperm bound on experimental hemizona/Number of sperm bound on control hemizona] ϫ 100.
Each sample was tested with 7-12 hemizonae obtained from 3-8 different women in three different experiments performed on different days using sperm from at least three different fertile men. For the immunoadsorption experiments, the FabЈs were incubated (4ЊC, overnight) with the peptide (1:10, w:w) and centrifuged (10 000 rpm, 5 min), and the supernatant was tested in the hemizona assay.
Interaction Between the Peptide and Oocyte ZP
The interaction between synthetic peptide and oocyte ZP proteins was examined by Western blot and immunoprecipitation. For Western blot analysis, the HZP was run in two identical SDS gels (5-15% gradient) and transferred to nitrocellulose membranes. BSA was biotinylated and separated from unbiotinylated protein according to the manufacturer's protocol (ECL protein biotinylation module; Amersham, Piscataway, NJ) [20] . The peptide was conjugated to biotinylated BSA by using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide as described above. The Western blots were incubated with blocking solution for 2 h at room temperature; then one blot was treated with the peptide-biotinylated BSA conjugate in PBS (20 g/20 ml) and the second identical blot was treated with biotinylated BSA not conjugated to peptide (20 g/20 ml). The blots were washed, reacted with streptavidin-horseradish peroxidase (1:1500), washed, incubated with substrate, and exposed to x-ray film for 1-5 min. BSA was used as a control in these experiments. For analysis using the immunoprecipitation procedure, the peptide was conjugated to BSA as described above, and the peptide-BSA conjugate or the BSA alone was coupled to cyanogen bromide-activated Sepharose 4B (Sigma) [21, 29] . HZP was divided into two aliquots of 20 g protein/50 l each. One aliquot was incubated with peptide-BSA-Sepharose 4B beads, and the second was incubated with the BSA-Sepharose 4B beads suspended in radioimmunoprecipitation assay buffer (50 mM NaCl, 10 mM Tris, 1 mM EDTA, 1 mM PMSF [30] . The reaction mixture was incubated for 2 h at 4ЊC; unadsorbed proteins were washed off, and the reacted zona protein was eluted from the beads by treating with glycine-HCl (0.1 M, pH 2.8). The eluate was neutralized with solid K 2 HPO 4 to pH 7.4, boiled with nonreduced SDS-sample buffer, and subjected to SDS-PAGE; the gel containing the resolved proteins was stained with silver nitrate and visualized.
Tissue-Specific Expression
To examine tissue-specific expression, the solubilized extracts from 10 different human tissues-namely, testis, kidney, liver, spleen, heart, lung, brain, muscle, ovary, and placenta (Human Protein Medley; Clontech, Palo Alto, CA)-were run in SDS-PAGE and transferred to nitrocellulose membrane for Western blot analysis. The membranes were probed with anti-peptide FabЈs/control FabЈs (15 g/ 10 ml), and the reacted bands were localized as described above [16, 20] .
Indirect Immunofluorescence Technique
Indirect immunofluorescence technique was performed on methanol-fixed sperm cells to examine the subcellular site at which the peptide sequence was present [31] . Motile sperm cells were collected from semen of fertile men by the swim-up procedure, washed (3 times) with PBS, air dried at room temperature, fixed in methanol, and air dried again. The slides were then rinsed in PBS and blocked with PBS containing 5% BSA for 45 min; next they were reacted with anti-peptide FabЈs in PBS (10 g/100 l) for 1.5 h at room temperature in a moist chamber. After washing in PBS, fluorescein isothiocyanate-labeled goat anti-rabbit IgG (1:40 dilution; Cappel Labs., Malvern, PA) was added and incubated as above for 1.5 h. The slides were washed, mounted in 90% glycerol in PBS containing sodium azide (0.1%) and 1,4-diazabicyclo(2,2,2)octane (10 mg/ml), and examined.
Capacitation was induced by incubating (6-8 h, 37ЊC in 5% CO 2 and 95% air mixture) the swim-up sperm (10 ϫ 10 6 sperm/ml) in Ham's F-10 medium containing 5% BSA. The capacitated sperm were washed, methanol fixed, and studied for antibody reactivity as described above.
Statistical Analysis
Significance of differences between treated and control groups in Tables 2 and 3 was analyzed by using unpaired and paired Student's t-test. A P value of Ͻ 0.05 was considered significant.
RESULTS
After biopanning ϳ1.2 ϫ 10 6 phage clones five times, 21 clones were selected that showed varied degrees of affinity for HZP. Clones were cultured in RM medium (Invitrogen) to obtain a larger quantity of protein for analysis in the Western blot procedure. Of these clones, 18 showed positive reactivity with HZP in the Western blot procedure, as seen by the presence of the expected ϳ53-kDa protein band. With loading of the same amount of total protein from each clone, 6 of the 18 clones showed a weaker band, and the remaining 12 showed a band of 3-to 5-fold stronger intensity. DNA from all 18 clones was isolated, purified, and sequenced using the FliTrx forward and reverse primers to obtain the sequence coding for the dodecamer. The clones were sequenced several times to confirm the sequence obtained. Twelve strongly reacting clones exhibited three aa sequences designated as SNR 12 , GHR 12 , and YLP 12 (Table 1) . SNR 12 designated as Consensus 17 , was obtained using the Lineup program including all nine (three strongly and six weakly reacting) sequences. An extensive computer search in GenBank, NBRF, and the Swiss sequence banks did not identify any known nt/aa sequence having a complete homology with these four sequences.
The peptides were synthesized based on these four sequences, and the purified peptides were examined for their effects on binding of human sperm with human ZP in the hemizona assay. Of these peptides, two, namely YLP 12 and Consensus 17 , caused a significant (P Ͻ 0.05) inhibition of sperm binding with ZP (Table 2, Fig. 1b) . The effects were concentration dependent, with a stronger inhibition at higher doses. The effect was much stronger with the YLP 12 as compared to Consensus 17 peptide at 75 mM concentration. The inhibition was apparent only when the hemizonae were treated with the peptides before coincubation with sperm, not vice versa. The other two peptides did not affect binding, and the results were similar to those with BSA control (Table 2 ). Further studies focused on the YLP 12 peptide. Immunization with YLP 12 peptide conjugated to TT raised high-titer (Ͼ 1:5120, ELISA titer) antibodies against the peptide. The immunoaffinity-purified FabЈs against the YLP 12 peptide significantly inhibited sperm-zona binding (Table 3 , Fig. 1d ). Control FabЈs from animals immunized with TT alone and with preimmune serum did not affect sperm binding. Immunoadsorption of the anti-YLP 12 FabЈs with purified peptide completely abolished inhibitory activity. The inhibition was apparent only when sperm were treated with the anti-YLP 12 FabЈs before coincubation with hemizona, not vice versa.
To examine the component of the human ZP that is recognized by the YLP 12 peptide, Western blot and immunoprecipitation procedures were performed. In Western blotting, the peptide YLP 12 conjugated to biotinylated BSA specifically reacted with the ZP3 component of human ZP and not with BSA (Fig. 2, Western blot, lanes Aa and Ab, FIG. 3 . Western blot indicating the testisspecific expression of YLP 12 peptide sequence. Solubilized extracts from 10 different human tissues were run in SDS-PAGE and transferred to nitrocellulose membrane for Western blot analysis. Anti-YLP 12 FabЈs (A) from postimmune serum, and not the FabЈs from control or preimmune serum (B), recognized a specific band of ϳ72 Ϯ 2 kDa (arrow) only in the testis. There were some nonspecific protein bands reactive in each tissue extract that were also recognized by the control FabЈs. The Western blot procedure was repeated seven times on different days using various concentrations (100-300 g protein per lane) of tissue extracts, and each time an identical pattern was obtained. Silver-stained SDS-PAGE of these tissue extracts showed multiple sharp and well-resolved protein bands without any smears.
respectively). The biotinylated BSA not conjugated to peptide did not react with HZP or BSA (Fig. 2 , Western blot, lanes Ba and Bb, respectively). In the immunoprecipitation procedure, similar results were obtained. The peptide conjugated to BSA coupled to Sepharose 4B beads pulled out the ZP3 component from HZP and nothing from the BSA solution (Fig. 2 , Immunoprecipitation, Aa and Ab, respectively). The BSA-Sepharose 4B beads not conjugated to peptide did not react with HZP or any protein in the HZP preparation or BSA solution (Fig. 2 , Immunoprecipitation, Ba and Bb, respectively).
Anti-YLP 12 FabЈs specifically recognized a protein band of ϳ72 Ϯ 2 kDa only in the testis lane in the Western blot procedure involving solubilized extracts of 10 different human tissues (Fig. 3) .
Anti-YLP 12 FabЈs reacted with the acrosomal region of the methanol-fixed human sperm cell, whether noncapacitated (Fig. 4b) or capacitated (Fig. 4d) . FabЈs from control or preimmune immunoglobulins did not bind to any region of the sperm cell (Fig. 4f) .
DISCUSSION
In the present study, we used phage display technology, a unique tool for identifying novel sequences. Previous studies have employed predominantly hybridoma technology to delineate fertilization-related antigens [1, 2, [13] [14] [15] [16] 20] , which is more laborious and time consuming. Using the peptide display library containing 1.77 ϫ 10 8 unique sequences, we identified at least three 12-mer aa sequences that showed stronger binding with human ZP. In addition, a 17-mer consensus sequence was delineated based upon these three strongly binding and six relatively weakly binding sequences. All four sequences were novel, since an extensive computer search in the GenBank, NBRF, and Swiss sequence banks did not show any known nt/aa sequence having a complete identity with them. All four synthetic peptides based on these sequences were water soluble.
When tested in the hemizona assay, only two, YLP 12 and Consensus 17 , significantly inhibited sperm binding, with YLP 12 having a stronger effect. The other two, SNR 12 and GHR 12 , did not inhibit sperm binding with hemizona, although these peptide sequences showed relatively stronger binding with HZP in the five cycles of biopanning and Western blotting. In both these screening procedures using solubilized HZP, the complementary linear sequences rather than conformational epitopes of the interacting molecules are involved in recognition and binding. In contrast to the situation with solubilized HZP, in the intact HZP the complementary sequences may be present as conformational epitopes and/or may not be exposed on the surface, thus not recognizable by the linear sequences of these peptides in the hemizona assay. Even if the complementary epitopes present on the intact ZP are accessible to these peptides, they may not be relevant to sperm binding. Some specific sequences present in ZP are involved in sperm binding, and others are not [21, [32] [33] [34] . Various studies have shown that the ZP of the human oocyte is composed of at least three components, namely, ZP1, ZP2, and ZP3, and the ZP3 molecule acts as a primary receptor for sperm binding in various species of animals [21, [32] [33] [34] . It is possible that SNR 12 and GHR 12 sequences react with ZP1 and/or ZP2 instead of ZP3 and thus are unable to inhibit sperm binding in the hemizona assay.
The inhibitory effects of YLP 12 and Consensus 17 peptides were specific, since 1) the second halves of the zonae (hemizonae) from the same oocyte that were used as controls showed sperm binding; 2) the effects of peptides were apparent only when they were preincubated with hemizonae instead of sperm before insemination; and 3) two other same-sized (12-mer) peptides (SNR 12 and GHR 12 ) and BSA did not affect binding at the same concentration. Also, the inhibitory effect of YLP 12 was further confirmed with use of its monovalent FabЈ antibodies, which are devoid of nonspecific binding Fc portion. Immunoadsorption of the anti-YLP 12 FabЈs with the peptide abolished the inhibitory effect, and the control FabЈs from preimmune serum and control animals immunized with the TT alone did not affect sperm binding, indicating specificity of the inhibitory effects. None of the peptides or the FabЈs caused agglutination of sperm or any apparent deleterious effect on motility (percent or progressive) of the spermatozoa. The YLP 12 peptide specifically recognized the ZP3 component of the ZP of the oocyte in Western blot and immunoprecipitation procedures. The binding with ZP3 and inhibition of sperm-zona binding by the peptide indicate that the YLP 12 sequence may be a complementary receptor sequence on the sperm surface that is involved in recognition/binding to the ZP of the oocyte. The interaction of ZP3 with the peptide also indicates that the recognition/ binding may involve protein-protein interaction, recognizing the linear sequences of the complementary molecules of two interacting cells (sperm/oocyte), as is becoming apparent from recent studies using recombinant ZP and sperm proteins [35] .
The specific binding of the FabЈs with the ϳ72 Ϯ 2-kDa protein band only in the testis extract indicates the testisspecific expression of the protein having the YLP 12 aa sequence. In addition to involvement in the fertilization process, tissue specificity is an important criterion for the selection of an antigen as a candidate for contraceptive vaccine development. The binding of the FabЈs with the acrosomal region of the noncapacitated as well as the capacitated sperm cell in the indirect immunofluorescence technique indicates that the ϳ72 Ϯ 2-kDa protein with YLP 12 sequence is present in the acrosomal subcellular region of the sperm cell and is not lost during capacitation.
In conclusion, by using the phage display technique we have identified a testis-specific novel peptide sequence, present in the acrosomal region of the human sperm cell, that is involved in recognition/binding to the ZP3 component of the ZP of human oocytes. Besides helping to provide further insight into molecular mechanisms underlying sperm-zona interaction, the sequence may find applications in contraceptive vaccine development and in diagnosis and treatment of male infertility mediated through sperm dysfunction.
